chr10-49482796-G-A
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_000124.4(ERCC6):c.2060C>T(p.Ser687Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S687S) has been classified as Likely benign.
Frequency
Consequence
NM_000124.4 missense
Scores
Clinical Significance
Conservation
Publications
- Cockayne spectrum with or without cerebrooculofacioskeletal syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Cockayne syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- UV-sensitive syndrome 1Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- UV-sensitive syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- premature ovarian failure 11Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ERCC6 | ENST00000355832.10 | c.2060C>T | p.Ser687Leu | missense_variant | Exon 10 of 21 | 1 | NM_000124.4 | ENSP00000348089.5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152030Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 0.00000752 AC: 11AN: 1461832Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727228 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152030Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74266 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
The c.2060C>T (p.S687L) alteration is located in exon 10 (coding exon 9) of the ERCC6 gene. This alteration results from a C to T substitution at nucleotide position 2060, causing the serine (S) at amino acid position 687 to be replaced by a leucine (L). Based on data from gnomAD, the T allele has an overall frequency of 0.003% (1/31324) total alleles studied. The highest observed frequency was 0.007% (1/15394) of European (non-Finnish) alleles. This variant has been identified in the homozygous state and/or in conjunction with other ERCC6 variant(s) in individual(s) with features consistent with Cockayne syndrome; in at least one instance, the variants were identified in trans (Laugel, 2010; Calmels, 2016). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic.
not provided Pathogenic:1
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 687 of the ERCC6 protein (p.Ser687Leu). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This missense change has been observed in individual(s) with Cockayne syndrome (PMID: 19894250, 27004399, 29572252). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 552600). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic.
Cockayne syndrome type 2 Pathogenic:1
Cerebrooculofacioskeletal syndrome 1;C0265201:DE SANCTIS-CACCHIONE SYNDROME;C0751038:Cockayne syndrome type 2 Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at